Illumina to pay $8B to reacquire cancer blood test maker Grail, with all eyes on 2021

·

·

Illumina to pay $8B to reacquire cancer blood test maker Grail, with all eyes on 2021

Illumina said it will continue to act as a sequencing partner for other diagnostic test makers while becoming a proprietary test provider itself, with Grail operating as a standalone division. (Illumina). Share Facebook Twitter LinkedIn Email Print. Illumina will put …
See Original Article

Dow tumbles more than 700 points as coronavirus fears mount

In a painful start to the week for the Dow and the broader market, stocks tumbled at the opening bell in New York as investors worry when Washington will agree another stimulus bill. Rising Covid-19 infections around the world as the colder seasons of the …
See Original Article

Vietnam Airlines passenger spread coronavirus to 15 on international flight, study claims

A recent study reveals that one passenger on an international flight was reportedly responsible for infecting 15 other people with COVID-19. Researchers reportedly used contact-tracing to track the infections back to this individual, who flew with Vietnam …
See Original Article

PNNL researchers working to understand offshore wind potential

Anyone who lives in the Tri-Cities knows about wind — or at least, we think we do. But at the U.S. Department of Energy’s Pacific Northwest National Laboratory, we have experts who study the wind and use that knowledge to develop technology to harness it …
See Original Article

2021 GMC Yukon Denali First Test Drive: You Win Some, You Lose Some

The first GMC Yukon Denali landed in 1998 with an explosive impact, causing a shockwave that propelled Denali to become the best-selling of all GMC trim levels—and a brand unto itself with more name recognition among some buyers than Yukon.
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.